2013
DOI: 10.1007/s13318-013-0155-8
|View full text |Cite
|
Sign up to set email alerts
|

A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents

Abstract: The purpose of this study was to evaluate the impact of structural modifications on the 15-membered macrolactone ring and/or substituents on the in vitro ADME properties and in vivo pharmacokinetic (PK) profile for selected derivatives in rodents in comparison to azithromycin. Azithromycin and seven selected 15-membered macrolide derivatives, modified either by removal of the sugar moieties, replacement of the amine with a lactam, or addition of lipophilic substituents, were screened in several in vitro ADME a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 36 publications
0
5
0
Order By: Relevance
“…The drugs were administered orally (by oral gavage) for 4 weeks: AZM (at a dose of 50 mg/kg) was administered once daily in the first week of the experiment and then 3 times a week (every second or third day), and LR (at a dose of 3 × 10 8 CFU/kg) was administered once daily throughout the experiment. The AZM dose was calculated [ 80 ] based on its antimicrobial dose used in patients and the antibiotic AZM dose, reported to affect the rat skeletal system [ 49 ], taking into consideration its bioavailability in rats [ 81 ]. The dose of the probiotic was chosen based on previous studies [ 82 , 83 ].…”
Section: Methodsmentioning
confidence: 99%
“…The drugs were administered orally (by oral gavage) for 4 weeks: AZM (at a dose of 50 mg/kg) was administered once daily in the first week of the experiment and then 3 times a week (every second or third day), and LR (at a dose of 3 × 10 8 CFU/kg) was administered once daily throughout the experiment. The AZM dose was calculated [ 80 ] based on its antimicrobial dose used in patients and the antibiotic AZM dose, reported to affect the rat skeletal system [ 49 ], taking into consideration its bioavailability in rats [ 81 ]. The dose of the probiotic was chosen based on previous studies [ 82 , 83 ].…”
Section: Methodsmentioning
confidence: 99%
“…A compound profile (Table 2) for azithromycin was created based on physiochemical properties and pharmacokinetic parameters [35][36][37][38][39][40][41]. Oral absorption was characterized using the ADAM module, and intrinsic solubility was predicted using the Simcyp ® prediction toolbox.…”
Section: Azithromycin Model Development and Verification In Healthy V...mentioning
confidence: 99%
“…In an additional study with P-gp inhibitor GF120918 (data not shown), this efflux ratio in clone 79 was diminished for erythromycin to unity. Erythromycin has been reported to give false negative identification as a P-gp substrate in MDR1-MDCK and MDCK-WT due to a high efflux ratio in WT cells and has shown poor in vitro permeability across other cell lines (12,32,33).…”
Section: Bi-directional Transport Across Different Cell Linesmentioning
confidence: 99%